DXCM 69.55 (-0.5%)
US2521311074Medical Diagnostics & ResearchDiagnostics & Research

DexCom (DXCM) Competitor Comparison

We are evaluating the key criteria listed to compare DexCom (DXCM) against its competitors in the Diagnostics & Research industry.

Performance 10 years - DXCM ranking 7 / 58

These are the competitors of DexCom in the industry Diagnostics & Research ranked by performance 10 years
1. Lantheus Holdings LNTH
1.73K
2. Heska HSKA
1.65K
3. Medpace Holdings MEDP
1.14K
4. RadNet RDNT
796.47
5. IDEXX Laboratories IDXX
692.46
6. Natera NTRA
622.56
7. DexCom DXCM
581.87
8. Mettler-Toledo MTD
503.05
9. Danaher DHR
456.81
10. Icon ICLR
440.05
11. Thermo Fisher Scientific TMO
413.04
12. CareDx CDNA
366.77
13. IQVIA Holdings IQV
329.33
14. Agilent Technologies A
274.2
15. Waters WAT
268.43
16. PerkinElmer PKI
247.07
17. Twist Bioscience TWST
242.08
18. Charles River Laboratories CRL
237.95
19. Exact Sciences EXAS
184.29
20. NeoGenomics NEO
182.46
21. Laboratory Corp of America Holdings LH
155
22. Quest Diagnostics DGX
154.44
23. Fulgent Genetics FLGT
115.42
24. Syneos Health SYNH
113.83
25. Qiagen QGEN
94.17
26. Meridian Bioscience VIVO
60.69
27. National Research NRC
39.39
28. Ortho Clinical Diagnostics Holdings OCDX
13.74
29. Neogen NEOG
-1.79
30. Illumina ILMN
-2.79
31. Inotiv NOTV
-14.81
32. Bioventus BVS
-19.67
33. Guardant Health GH
-22.88
34. Olink Holding OLK
-26.82
35. Myriad Genetics MYGN
-36.35
36. Anixa Biosciences ANIX
-36.63
37. Sotera Health SHC
-43.26
38. Sera Prognostics SERA
-53.36
39. Pacific Biosciences of California PACB
-60.16
40. Global Cord Blood CO
-66.57
41. DarioHealth DRIO
-75.47
42. Enzo Biochem ENZ
-76.49
43. MaxCyte MXCT
-77.16
44. bioAffinity Technologies BIAF
-77.26
45. Co-Diagnostics CODX
-78.67
46. Personalis PSNL
-79.96
47. Psychemedics PMD
-83.49
48. MDxHealth MDXH
-83.54
49. Exagen XGN
-84.23
50. Biodesix BDSX
-87.56
51. SeqLL SQL
-95.22
52. Prenetics Global PRE
-96.41
53. Neuronetics STIM
-97
54. Aspira Womens Health AWH
-97.44
55. Trinity Biotech TRIB
-97.74
56. Interpace Biosciences IDXG
-98.96
57. Organovo Holdings ONVO
-99.26
58. Precipio PRPO
-99.75

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.